Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2024-10-04 Major Shareholding Noti…
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification
2024-10-04 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-09-10 English
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-09-10 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-09-10 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated September 5, 2024, by OraSure Technologies, Inc. The key content is an announcement regarding an increase in the number of directors on the Board and the appointment of a new director, John P. Kenny. There is no financial data, earnings information, or detailed report content. The focus is on changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is about 5,159 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2024-09-09 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by OraSure Technologies, Inc. on August 12, 2024. Form S-8 is used to register securities to be offered under employee benefit plans, such as stock award plans. The document details an increase in shares reserved for the company's 2000 Stock Award Plan and incorporates by reference various prior filings including annual reports (10-K), quarterly reports (10-Q), and proxy statements (DEF 14A). It is not a financial report, earnings release, or management discussion, but a registration statement related to stock awards. This type of filing is best classified under Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit into other specific categories like capital/financing update or share issue announcements, since it is specifically a registration statement for employee stock plans.
2024-08-12 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.